Cargando…
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
BACKGROUND: The benefit of clopidogrel monotherapy after 1-month dual antiplatelet therapy (DAPT) compared with 12-month DAPT with aspirin and clopidogrel was demonstrated in the STOPDAPT-2 (Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2), bu...
Autores principales: | Obayashi, Yuki, Watanabe, Hirotoshi, Morimoto, Takeshi, Yamamoto, Ko, Natsuaki, Masahiro, Domei, Takenori, Yamaji, Kyohei, Suwa, Satoru, Isawa, Tsuyoshi, Watanabe, Hiroki, Yoshida, Ruka, Sakamoto, Hiroki, Akao, Masaharu, Hata, Yoshiki, Morishima, Itsuro, Tokuyama, Hideo, Yagi, Masahiro, Suzuki, Hiroshi, Wakabayashi, Kohei, Suematsu, Nobuhiro, Inada, Tsukasa, Tamura, Toshihiro, Okayama, Hideki, Abe, Mitsuru, Kawai, Kazuya, Nakao, Koichi, Ando, Kenji, Tanabe, Kengo, Ikari, Yuji, Morino, Yoshihiro, Kadota, Kazushige, Furukawa, Yutaka, Nakagawa, Yoshihisa, Kimura, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371064/ https://www.ncbi.nlm.nih.gov/pubmed/35912647 http://dx.doi.org/10.1161/CIRCINTERVENTIONS.122.012004 |
Ejemplares similares
-
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023) -
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
por: Natsuaki, Masahiro, et al.
Publicado: (2015) -
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
por: Yamamoto, Ko, et al.
Publicado: (2023) -
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018) -
Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions
por: Nagao, Kazuya, et al.
Publicado: (2019)